Securities Registration (section 12(b)) (8-a12b)
September 03 2019 - 8:18AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE
SECURITIES EXCHANGE ACT OF 1934
BELLUS HEALTH INC.
(Exact name of registrant as specified
in its charter)
Canada
|
|
Not applicable
|
(State of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
275 Armand-Frappier Blvd.
Laval, Quebec, Canada
|
|
H7V 4A7
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Securities to be registered pursuant
to Section 12(b) of the Act:
Title of each class
to be so registered
|
Name of each exchange on which
each class is to be registered
|
Common Shares
|
The NASDAQ Stock Market LLC
|
If this Form 8-A relates to the registration
of a class of securities pursuant to Section 12(b) of the Exchange Act and is to become effective pursuant to General Instruction
A.(c), please check the following box. x
If this Form 8-A relates to the registration
of a class of securities pursuant to Section 12(g) of the Exchange Act and is to become effective pursuant to General Instruction
A.(d), please check the following box. ¨
If this form relates to the registration
of a class of securities concurrently with a Regulation A offering, check the following box ¨
Securities Act registration statement
file number to which this form relates: 333-233592
Securities to be registered pursuant
to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1.
|
Description of Registrant’s Securities to be Registered.
|
The securities to be registered consist of common shares,
no par value (“Common Shares”) of BELLUS Health Inc. (the “Registrant”). The
description of the Registrant’s Common Shares under the section captioned “Description of Share Capital –
Common Shares” in the short form base shelf prospectus and under the sections captioned “Description of Capital
Structure – Common Shares”, “Certain Canadian Federal Income Tax Considerations”, and “Material
United States Federal Income Tax Considerations for U.S. Holders” in the prospectus supplement to the
short form base shelf prospectus, each included in the Registrant’s registration statement on Form F-10 (File No.
333-233592) (the “Registration Statement”), initially filed with the Securities and Exchange Commission
on September 3, 2019, as subsequently amended by any amendments to such Registration Statement, is incorporated herein by
reference.
Under the “Instructions as to Exhibits” section
of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The NASDAQ
Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
Dated: September 3, 2019
|
BELLUS HEALTH INC.
|
|
|
|
By:
|
/s/ Roberto Bellini
|
|
|
Roberto Bellini
|
|
|
President and Chief Executive Officer
|